Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
15.13
-0.22 (-1.43%)
At close: Oct 5, 2026, 4:00 PM EDT
15.29
+0.16 (1.06%)
After-hours: Oct 5, 2026, 5:24 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $250.87 million as of October 5, 2026. Its market cap has increased by 225.81% in one year.
Market Cap
250.87M
Enterprise Value
97.31M
1-Year Change
225.81%
Ranking
Category
Stock Price
$15.13
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $336.80M to $250.87M, a decrease of -25.51%. That is a compound annual growth rate of -3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 250.87M | 154.69% |
| Dec 31, 2025 | 98.50M | -35.07% |
| Dec 31, 2024 | 151.70M | -41.99% |
| Dec 29, 2023 | 261.50M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -17.85% |
| Dec 31, 2020 | 838.10M | 229.96% |
| Dec 31, 2019 | 254.00M | 23.24% |
| Dec 31, 2018 | 206.10M | -38.81% |
| Sep 27, 2018 | 336.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 263.32M |
| Vicore Pharma Holding AB | 261.45M |
| Pyxis Oncology | 255.64M |
| InflaRx | 253.47M |
| Evommune | 251.14M |
| Camp4 Therapeutics | 251.01M |
| Palisade Bio | 250.95M |
| Nautilus Biotechnology | 249.42M |